Pacemakers (Russian market)

Main article: Pacemakers

Pacemakers (Global Market)

Main Article: Pacemakers (Global Market)

Chronicle

2023: 8.5% reduction in sales to RUB 2.7 billion

In 2023, sales of pacemakers of imported and domestic production in Russia amounted to about 2.7 billion rubles. This is 8.5% less compared to the previous year, when the market volume was estimated at 3 billion rubles. Such data are given in the review of the analytical agency "GuideMarket," published on August 25, 2024.

The study says that the most popular on the Russian market are implantable two-chamber and three-chamber electrocardiostimulants (ECS), which can control and stimulate the work of two and three heart chambers, respectively. Single-chamber devices are used less often because they have limited functionality and are not able to ensure optimal heart function in patients with complex forms of arrhythmia.

According to estimates, in 2019, the total sales of pacemakers of imported and domestic production in the Russian Federation amounted to 2.07 billion rubles. In 2020, there was a decrease of 12.6% - to 1.81 billion rubles. The review notes that the Russian pacemaker market remains dependent on foreign supplies. Therefore, against the background of the COVID-19 pandemic, which provoked a disruption in the supply chains, there was a drop in sales.

In 2021, the industry began to recover, showing an increase of 11.4% with a final result of 2 billion rubles. In 2022, there was an increase in sales by another 48.1%, but in 2023 there was a decline. Due to the deteriorating geopolitical situation, there was a shortage of medical devices for patients with heart pathologies, the work of both state and commercial medical organizations became much more complicated. Problems with the import of equipment, consumables and components led to an increase in the cost of services of private clinics. On the other hand, the formed situation led to the accelerated development of import substitution of goods in the field of cardiology.^[1]

Notes